Dark Mode Light Mode

The FDA must stop the pharmaceutical company to cross the stage.

Spread the love


Recent Headline He emphasized the acceleration approval program of the Food and Drug Administration for the New Testament, and the treatment approved in this way was actually effective. The program quickly treated many life -long treatment for the late and rare diseases, but there is a serious difficulty in complete the required clinical trial after approval. What can you do to restart this exam? I wrote about this in Boston Globe today.

“When the drug accelerates, the company goes to the market and the company immediately gains profits. The officer office found that Medicare and Medicaid spent. $ 18 billion The approval has been accelerated, but in three years in drugs with incomplete clinical trials. ”

Read the entire piece here.

The study of this article was supported by Arnold Ventures.



Source link

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Add a comment Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

MISSION ACT SCRIBES Pilot: Implementation and cost

Next Post

What is Candidozyma Auris? Fungal pathogens and emerging world health threats -UK health security institutions